ADME Toxicology Testing Market by Product Type (Microarray, Instruments, Software Solutions, Assays Systems, Reagents, Others), by Technology Type (Oncology, In-vitro Tests, In-vivo Tests): Size, Share, Industry Growth & Forecast to 2027

Publisher: GB Market Research | Published on: 10 Mar 2021| Category: Medical Devices|

The global ADME toxicology testing market is expected to grow at the CAGR of 10.2% during 2020-2027. The global ADME toxicology testing market is segmented on the basis of product type, technology type and geography. The report on global ADME toxicology testing market forecast 2017-2025 (by product type, technology and geography) provides a detailed overview and predictive analysis of the market.

ADME toxicology is a novel concept that is being used in market for drug discovery, development and testing in pharmaceutical and biotechnology companies. ADME stands for absorption, distribution, metabolism and elimination process which takes place when drug is consumed by human body. Thus ADME process helps in understanding the drug performance on human tissue. The key drivers of the market include rapid adoption of in silico and in vitro toxicology testing, and cell based assay systems in drug development and discovery and ADME analysis

ADME abbreviation stands for absorption distribution, metabolism and elimination, terms used in pharmacokinetics and pharmacology to describe the drug disposition in human tissue. These set processes help in monitoring the performance of drug in human tissue. It is widely used in biotechnology and pharmaceutical companies as it reduces the time and cost of drug discovery and development, toxicity testing. Prior to ADME, drug failure at later stages was higher; thus to avoid this hurdle in drug development, rapid adoption of ADME toxicity testing is observed in clinical trials. Furthermore, rise in adoption of ADME toxicity testing which help in reducing the cost and time drug development is the main driver of the market growth.

Market Segment Insights:

The global ADME toxicology testing market is majorly segmented by product type into instruments, software solutions, assays systems, reagent and others. Instruments and assay systems accounted for the largest market share in the global ADME toxicology testing market. On the basis of technology type, global ADME toxicology testing market is majorly segmented into in-vitro tests and in-vivo tests. In-vivo tests accounted the largest share in the market in terms of revenue due to its efficiency in terms of cost and time over other toxicity testing techniques.

Global ADME Toxicology Testing Market Segmentation:

By Product Type, 2018–2027 ($ Million)

  • Microarray
  • Instruments
  • Software Solutions
  • Assays Systems
  • Reagents
  • Others

By Technology Type, 2018–2027 ($ Million)

  • Oncology
  • In-vitro Tests
    • Biochemical Testing
    • Cell Testing
  • In-vivo Tests

By Geography, 2018–2027  ($ Million

  • North America (U.S. & Canada)
  • Europe (U.K., Germany & Rest of Europe)
  • Asia Pacific (China, Japan, and Rest of APAC)
  • Latin America (Brazil, Mexico and Rest of LATAM)                                       
  • Middle East and Africa (UAE, Saudi Arabia, South Africa)

Regional Insights:

North America occupies the largest revenue share for global ADME toxicology testing market, largely dominated by the U.S. Asia Pacific is expected to be the most attractive market and anticipates extensive growth during the forecast period. Major drivers for the growth are rapid adoption of ADME toxicology testing, government initiative and support in new drug development and toxicology testing.

Market Competition Assessment:

Key players in the ADME toxicology testing market are AMD Telemedicine, Philips Healthcare, GE Healthcare, Allscripts Healthcare Solutions, Honeywell Life Care Solutions, McKesson Corporation, Cisco Systems, Siemens Healthcare, Robert Bosch Healthcare and others.

List of Key Companies:

  • Cellartis AB
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Caliper Life Sciences, Inc.
  • Promega Corporation
  • Beckman Coulter, Inc.
  • Optivia Biotechnology, Inc.
  • Cyprotex PLC
  • Molecular Discovery Ltd.
  • Others

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary

2.1 ADME Toxicology Testing Market, by Product Type, 2019 ($ Million)

2.2 ADME Toxicology Testing Market Share, by Technology Type, 2019 (Value %)

2.3 ADME Toxicology Testing Market Share, by Geography, 2019 (Value %)

Chapter 3 Global ADME Toxicology Testing Market: Market Dynamics and Outlook

3.1 ADME Toxicology Testing: Current and Future Trends

3.2 Drivers

3.3 Challenges

3.4 Future Prospects

3.5 Attractive Investment Proposition

3.6 Market Share Analysis: Key ADME Toxicology Testing Manufacturers, 2019 (Value %)

Chapter 4 Global ADME Toxicology Testing Market, by Product Type, 2018-2027 ($ Million)

4.1 Preface

4.2 Instruments

4.3 Software Solutions

4.4 Assays systems

4.5 Reagents

4.6 Others

Chapter 5 Global ADME Toxicology Testing Market, by Technology Type, 2018-2027 ($ Million)

5.1 Preface

5.2 In-vitro Tests

5.2.1 Biochemical Testing

5.2.2 Cell Testing

5.3 In-vivo Tests

Chapter 6 Global ADME Toxicology Testing Market, by Geography, 2018-2027 ($ Million)

6.1 Preface

6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan, and Rest of APAC)
6.5 Latin Americas (Brazil, Mexico and Rest of LATAM) 
6.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)

Chapter 8 Company Profiles

8.1 Cellartis AB

8.2 Thermo Fisher Scientific, Inc.

8.3 Agilent Technologies, Inc.

8.4 Bio-Rad Laboratories, Inc.

8.5 Caliper Life Sciences, Inc.

8.6 Promega Corporation

8.7 Beckman Coulter, Inc.

8.8 Optivia Biotechnology, Inc.

8.9 Cyprotex PLC

8.10 Molecular Discovery Ltd.

List of Tables

NA

List of Figures

NA

List of Key Companies:

  • Cellartis AB
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Caliper Life Sciences, Inc.
  • Promega Corporation
  • Beckman Coulter, Inc.
  • Optivia Biotechnology, Inc.
  • Cyprotex PLC
  • Molecular Discovery Ltd.
  • Others
Select License Type
Single User: $3600
Multi User: $4800
Corporate User: $6800
Why To Choose Us:
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client base has an annual subscription membership
  • 24x7 availability – we are always there when you need us
  • 100,000+ data points in our comprehensive database
For Any Assitance
Call Us: +91 9893685690
Contact Person: Mr. Vijendra Singh
Contact Email: sales@gbmarketresearch.com